Treatment of chronic hepatitis C in treatment-naïve patients

Treatment of chronic hepatitis C in treatment-naïve patients

Bibliographic Details
Main Author:	Marcelo Simão Ferreira
Format:	Article
Language:	English
Published:	Elsevier
Series:	Brazilian Journal of Infectious Diseases
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702007000700015&lng=en&tlng=en

Similar Items

Treatment of chronic hepatitis C in treatment-naïve patients
by: Isaac Quintero Samudio
Published: (2006-01-01)

Chronic hepatitis C treatment in näive patients
by: Jorge Daruich
Published: (2010-01-01)

Treatment Response to Sofosbuvir and Ribavirin in Chronic Hepatitis C Patients and Comparison of Naive and Treatment Experienced Patients
by: Muhammad Ikhlaq, et al.
Published: (2018-12-01)

Cost-effectiveness of antiviral therapy in treatment-naive patients with chronic hepatitis C (genotype 1)
by: A. V. Rudakova, et al.
Published: (2017-06-01)

Cost-effectiveness of narlaprevir in the chronic hepatitis C (genotype 1) therapy in treatment-naïve patients and relapsers
by: D. A. Gusev, et al.
Published: (2016-11-01)

Autoimmunity and Extrahepatic Manifestations in Treatment-Naïve Children with Chronic Hepatitis C Virus Infection
by: Giuseppe Indolfi, et al.
Published: (2012-01-01)

Simeprevir in combination with pegylated interferon-α and ribavirin in the treatment of naïve patients with genotype 1 chronic hepatitis C
by: É Z Burnevich
Published: (2014-11-01)

Efficacy of Real-world Entecavir Therapy in Treatment-naïve Chronic Hepatitis B Patients
by: Yan-Di Xie, et al.
Published: (2017-01-01)

Cost-effectiveness of daclatasvir plus asunaprevir for chronic hepatitis C genotype 1b treatment-naïve patients in China.
by: Yun Lu, et al.
Published: (2018-01-01)

Efficacy of triple therapy with interferon alpha-2b, ribavirin and amantadine in the treatment of naïve patients with chronic hepatitis C
by: Hamid Kalantari, et al.
Published: (2007-08-01)

Cost-utility analysis of triple therapy with telaprevir in treatment-naïve hepatitis C patients
by: Blanca Gros, et al.
Published: (2014-09-01)

Virologic response and safety of tenofovir versus entecavir in treatment-naïve chronic Hepatitis B patients
by: Hyung Min Yu, et al.
Published: (2015-01-01)

Corrigendum: Efficacy of Real world Entecavir Therapy in Treatment NaïveChronic Hepatitis B Patients
Published: (2017-01-01)

Efficacy and safety of long term entecavir in chronic hepatitis B treatment naïve patients in clinical practice
by: Ezequiel Ridruejo, et al.
Published: (2014-05-01)

Genetic polymorphisms of vitamin D pathway predict antiviral treatment outcome in slow responder naïve patients with chronic hepatitis C.
by: Edmondo Falleti, et al.
Published: (2013-01-01)

Factors Influencing the Prevalence of Resistance-Associated Substitutions in NS5A Protein in Treatment-Naive Patients with Chronic Hepatitis C
by: Karen K. Kyuregyan, et al.
Published: (2020-04-01)

COST-EFFECTIVENESS OF ANTIVIRAL THERAPY IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS C (GENOTYPE 1) WITH VARIOUS SEVERITY OF FIBROSIS STAGE
by: A. V. Rudakova, et al.
Published: (2018-01-01)

Pre-existing mutations in reverse transcriptase of hepatitis B virus in treatment-naive Chinese patients with chronic hepatitis B.
by: Jie Xu, et al.
Published: (2015-01-01)

Natural YMDD motif mutations in treatment naïve patients with chronic hepatitis B in Huzhou of eastern China
by: Fuchu Qian, et al.
Published: (2016-11-01)

Efficacy and safety of glecaprevir/pibrentasvir in treatment-naïve adults with chronic hepatitis C virus genotypes 1–6 in Brazil
by: Mario Peribañez-Gonzalez, et al.
Published: (2021-01-01)

Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B
by: Won Sohn, et al.
Published: (2017-06-01)

A real-world impact of cost-effectiveness of pegylated interferon/ribavarin regimens on treatment-naïve chronic hepatitis C patients in Taiwan
by: Pei-Chien Tsai, et al.
Published: (2017-01-01)

Predictors of Response to 24-Week Telaprevir-Based Triple Therapy for Treatment-Naïve Genotype 1b Chronic Hepatitis C Patients
by: Hiroshi Abe, et al.
Published: (2014-01-01)

YMDD motif mutations in chronic hepatitis B antiviral treatment naïve patients: a multi-center study
by: You-Wen Tan, et al.

YMDD motif mutations in chronic hepatitis B antiviral treatment naïve patients: a multi-center study
by: You-Wen Tan, et al.
Published: (2012-05-01)

High versus standard doses interferon-alpha in the treatment of naïve chronic hepatitis C patients in Taiwan: a 10-year cohort study
by: Tsai Jung-Fa, et al.
Published: (2005-04-01)

Effect of vitamin D supplementation on sustained virological response in genotype 1/4 chronic hepatitis C treatment-naïve patients from India
by: Manas Kumar Behera, et al.
Published: (2018-01-01)

Antiviral treatment for treatment-naïve chronic hepatitis B: systematic review and network meta-analysis of randomized controlled trials
by: William W. L. Wong, et al.
Published: (2019-08-01)

The Effectiveness of Sovodak in the Treatment of Patients with Chronic Hepatitis C
by: Farshad Talebian, et al.
Published: (2021-03-01)

Treatment of chronic hepatitis C infection in cirrhotic patients
by: Lucy Dagher
Published: (2006-01-01)

Fibrosis progression in interferon treatment-naive Chinese plasma donors with chronic hepatitis C for 20 years: a cohort study
by: Jun-Feng Li, et al.
Published: (2014-10-01)

Raltegravir in treatment naïve patients
by: Cossarini F, et al.
Published: (2009-11-01)

Reverse-Transcriptase Characteristics of Hepatitis B Virus Polymerase Gene in Treatment-Naïve Asymptomatic Chronic Hepatitis B Individuals
by: Turyadi Turyadi, et al.
Published: (2018-01-01)

Hepatitis C viral evolution in genotype 1 treatment-naïve and treatment-experienced patients receiving telaprevir-based therapy in clinical trials.
by: Tara L Kieffer, et al.
Published: (2012-01-01)

Treatment outcomes of treatment-naïve Hepatitis C patients co-infected with HIV: a systematic review and meta-analysis of observational cohorts.
by: Anna Davies, et al.
Published: (2013-01-01)

Comparison of first-year results of tenofovir and entecavir treatments of nucleos(t)ide-naive chronic hepatitis B patients with hepatosteatosis
by: Zeynal Dogan, et al.
Published: (2015-01-01)

Clinical impact of the early alanine amininotransferase flare during tenofovir monotherapy in treatment-naïve patients with chronic hepatitis B
by: Hee Yeon Seo, et al.
Published: (2017-06-01)

Clinical role of obinutuzumab in the treatment of naive patients with chronic lymphocytic leukemia
by: Cerquozzi S, et al.
Published: (2015-02-01)

Clinical effect of 3D regimen (paritaprevir/ritonavir/ombitasvir combined with dasabuvir) in treatment-naive patients with genotype 1b chronic hepatitis C
by: WANG Bowen, et al.
Published: (2017-06-01)

Emerging treatments for chronic hepatitis C
by: C. Nelson Hayes, et al.
Published: (2015-03-01)